Clinical trial
Assessment and Prognostic Significance of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements During Regadenoson Stress Cardiac Magnetic Resonance
NCT02697877 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment and Prognostic Significance of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements During Regadenoson Stress Cardiac Magnetic Resonance
- Lead sponsor
- University of Illinois at Chicago
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- July 31, 2018
- Enrollment
- 183 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.